{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:30:48Z","timestamp":1786984248588,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ajo.2024.03.010","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T13:25:40Z","timestamp":1710941140000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Diagnostic Utility of QuantiFERON-Gold Testing in Patients with Ocular Inflammation in a Low-Endemic Tuberculosis Region"],"prefix":"10.1016","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0843-7245","authenticated-orcid":false,"given":"JULIA","family":"XIA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6361-6767","authenticated-orcid":false,"given":"ALAN G.","family":"PALESTINE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5097-823X","authenticated-orcid":false,"given":"AMIT K.","family":"REDDY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2024.03.010_bib0001","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ophtha.2020.01.008","article-title":"Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis-report 1: guidelines for initiating antitubercular therapy in tubercular choroiditis","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2024.03.010_bib0002","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/09273948.2016.1178304","article-title":"Diagnosis of ocular tuberculosis","volume":"26","author":"Ang","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.010_bib0003","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ophtha.2010.08.011","article-title":"Ocular tuberculosis: a clinicopathologic and molecular study","volume":"118","author":"Wroblewski","year":"2011","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2024.03.010_bib0004","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/09273948.2017.1406529","article-title":"The collaborative ocular tuberculosis study (COTS)-1 report 3: polymerase chain reaction in the diagnosis and management of tubercular uveitis: global trends","volume":"27","author":"Agarwal","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.ajo.2024.03.010_bib0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ophtha.2020.06.052","article-title":"Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis-report 2: guidelines for initiating antitubercular therapy in anterior uveitis, intermediate uveitis, panuveitis, and retinal vasculitis","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.03.010_bib0006","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajo.2021.03.040","article-title":"Classification criteria for tubercular uveitis","volume":"228","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2024.03.010_bib0007","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.survophthal.2021.02.002","article-title":"Rational laboratory testing in uveitis: a Bayesian analysis","volume":"66","author":"McKay","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2024.03.010_bib0008","unstructured":"CDC. Reported tuberculosis in the United States. cdc.gov."},{"key":"10.1016\/j.ajo.2024.03.010_bib0009","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajo.2019.11.009","article-title":"Prevalence of positive quantiFERON-TB gold in-tube test in uveitis and its clinical implications in a country nonendemic for tuberculosis","volume":"211","author":"Groen-Hakan","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.03.010_bib0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajo.2021.04.024","article-title":"The Association between QuantiFERON-TB gold test and clinical manifestations of uveitis in the United States","volume":"230","author":"Yakin","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.010_bib0011","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/bjophthalmol-2021-318868","article-title":"Usefulness of the QuantiFERON test for the diagnosis of tubercular uveitis and the predictions of response to antituberculosis treatment","volume":"107","author":"Danjou","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.010_bib0012","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/bjophthalmol-2021-318868","article-title":"Usefulness of the QuantiFERON test for the diagnosis of tubercular uveitis and the predictions of response to antituberculosis treatment","volume":"107","author":"Danjou","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2024.03.010_bib0013","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.010_bib0014","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ccm.2019.07.003","article-title":"Tuberculosis and Biologic Therapies: Anti-Tumor Necrosis Factor-alpha and Beyond","volume":"40","author":"Godfrey","year":"2019","journal-title":"Clin Chest Med"},{"issue":"11","key":"10.1016\/j.ajo.2024.03.010_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140881","article-title":"Tuberculosis infection in the United States: prevalence estimates from the national health and nutrition examination survey, 2011-2012","volume":"10","author":"Miramontes","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ajo.2024.03.010_bib0016","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.2022.24362","article-title":"Management of latent tuberculosis infection","volume":"329","author":"Kim","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ajo.2024.03.010_bib0017","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00006982-199515060-00001","article-title":"Intraocular tuberculosis. Clinicopathologic study of five cases","volume":"15","author":"Biswas","year":"1995","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.ajo.2024.03.010_bib0018","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1001\/archopht.124.12.1777","article-title":"Tuberculous uveitis: distribution of Mycobacterium tuberculosis in the retinal pigment epithelium","volume":"124","author":"Rao","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.010_bib0019","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/09273948.2015.1056536","article-title":"Pathogenesis and pathology of intraocular tuberculosis","volume":"23","author":"Basu","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.ajo.2024.03.010_bib0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/09273948.2014.986584","article-title":"The role of anti-tubercular therapy in patients with presumed ocular tuberculosis","volume":"23","author":"Agrawal","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.ajo.2024.03.010_bib0021","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjophthalmol-2011-300209","article-title":"Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study","volume":"96","author":"Ang","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2024.03.010_bib0022","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ajo.2008.06.011","article-title":"Role of anti-tubercular therapy in uveitis with latent\/manifest tuberculosis","volume":"146","author":"Bansal","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.03.010_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2023.101189","article-title":"The immune response in tubercular uveitis and its implications for treatment: From anti-tubercular treatment to host-directed therapies","volume":"95","author":"Putera","year":"2023","journal-title":"Prog Retin Eye Res"},{"issue":"13","key":"10.1016\/j.ajo.2024.03.010_bib0024","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1167\/iovs.17-22462","article-title":"Autoreactive T Cells in Immunopathogenesis of TB-Associated Uveitis","volume":"58","author":"Tagirasa","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2024.03.010_bib0025","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.ophtha.2009.05.021","article-title":"Uveitis in a patient treated with Bacille-Calmette-Guerin: possible antigenic mimicry of mycobacterial and retinal antigens","volume":"116","author":"Garip","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.03.010_bib0026","first-page":"565","article-title":"Aqueous cytokine and chemokine analysis in uveitis associated with tuberculosis","volume":"18","author":"Ang","year":"2012","journal-title":"Mol Vis"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.010_bib0027","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ajo.2013.11.013","article-title":"Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis","volume":"157","author":"La Distia Nora","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2024.03.010_bib0028","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.20040429","article-title":"Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis","volume":"201","author":"Song","year":"2005","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.ajo.2024.03.010_bib0029","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tube.2005.09.004","article-title":"Serum anti-mycobacterial heat shock proteins antibodies in sarcoidosis and tuberculosis","volume":"86","author":"Dubaniewicz","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.010_bib0030","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ajo.2013.12.021","article-title":"Caveats about QuantiFERON-TB gold in-tube testing for uveitis","volume":"157","author":"Pepple","year":"2014","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424001168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424001168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T16:00:40Z","timestamp":1737388840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939424001168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":30,"alternative-id":["S0002939424001168"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2024.03.010","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Utility of QuantiFERON-Gold Testing in Patients with Ocular Inflammation in a Low-Endemic Tuberculosis Region","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2024.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}